Using inverse electron demand Diels–Alder (IEDDA) reaction on 177Lu-labeled Tz radioligand and an immunoconjugate of the huA33 antibody (huA33-TCO) they improved pretargeted radioimmunotherapy (PRIT).
Â
Read: http://bit.ly/2JfoCzF
at the City University of New York